REGN logo

REGN Gross Profit

Annual Gross Profit

$12.23 B
+$930.10 M+8.23%

December 31, 2024


Summary


Performance

REGN Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

Quarterly Gross Profit

$3.22 B
-$5.80 M-0.18%

December 31, 2024


Summary


Performance

REGN Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

TTM Gross Profit

$12.23 B
+$306.50 M+2.57%

December 31, 2024


Summary


Performance

REGN TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

REGN Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.2%+10.5%+8.2%
3 y3 years-10.3%+10.5%+8.2%
5 y5 years+111.2%+10.5%+8.2%

REGN Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.3%+15.3%-18.8%+25.9%-12.5%+15.3%
5 y5-year-10.3%+111.2%-27.5%+100.1%-12.5%+111.2%
alltimeall time-10.3%>+9999.0%-27.5%>+9999.0%-12.5%>+9999.0%

Regeneron Pharmaceuticals Gross Profit History

DateAnnualQuarterlyTTM
Dec 2024
$12.23 B(+8.2%)
$3.22 B(-0.2%)
$12.23 B(+2.6%)
Sep 2024
-
$3.23 B(+5.3%)
$11.93 B(+2.6%)
Jun 2024
-
$3.07 B(+13.1%)
$11.62 B(+2.8%)
Mar 2024
-
$2.71 B(-7.1%)
$11.31 B(+0.1%)
Dec 2023
$11.30 B(+6.5%)
$2.92 B(-0.3%)
$11.30 B(+0.4%)
Sep 2023
-
$2.93 B(+6.3%)
$11.26 B(+2.8%)
Jun 2023
-
$2.75 B(+1.8%)
$10.95 B(+1.8%)
Mar 2023
-
$2.70 B(-5.9%)
$10.76 B(+1.4%)
Dec 2022
$10.61 B(-22.2%)
$2.87 B(+9.8%)
$10.61 B(-9.4%)
Sep 2022
-
$2.62 B(+2.3%)
$11.71 B(-3.2%)
Jun 2022
-
$2.56 B(-0.0%)
$12.09 B(-13.5%)
Mar 2022
-
$2.56 B(-35.5%)
$13.97 B(+2.5%)
Dec 2021
$13.63 B(+84.8%)
$3.97 B(+32.3%)
$13.63 B(+16.2%)
Sep 2021
-
$3.00 B(-32.5%)
$11.73 B(+9.1%)
Jun 2021
-
$4.44 B(+100.2%)
$10.76 B(+34.7%)
Mar 2021
-
$2.22 B(+7.3%)
$7.99 B(+8.3%)
Dec 2020
$7.38 B(+27.4%)
$2.07 B(+2.5%)
$7.38 B(+6.2%)
Sep 2020
-
$2.02 B(+20.5%)
$6.95 B(+7.8%)
Jun 2020
-
$1.68 B(+4.1%)
$6.45 B(+3.9%)
Mar 2020
-
$1.61 B(-1.9%)
$6.20 B(+7.1%)
Dec 2019
$5.79 B(+22.5%)
$1.64 B(+8.1%)
$5.79 B(+31.3%)
Sep 2019
-
$1.52 B(+6.0%)
$4.41 B(-0.8%)
Jun 2019
-
$1.43 B(+19.3%)
$4.45 B(-1.9%)
Mar 2019
-
$1.20 B(+358.0%)
$4.53 B(-4.1%)
Dec 2018
$4.73 B(-13.6%)
$262.10 M(-83.1%)
$4.73 B(-20.4%)
Sep 2018
-
$1.55 B(+2.4%)
$5.94 B(+2.7%)
Jun 2018
-
$1.52 B(+8.6%)
$5.79 B(+2.6%)
Mar 2018
-
$1.40 B(-5.4%)
$5.64 B(+3.0%)
Dec 2017
$5.48 B(+20.0%)
$1.48 B(+5.7%)
$5.48 B(+6.3%)
Sep 2017
-
$1.40 B(+2.1%)
$5.15 B(+4.5%)
Jun 2017
-
$1.37 B(+10.7%)
$4.93 B(+4.8%)
Mar 2017
-
$1.23 B(+7.2%)
$4.71 B(+3.2%)
Dec 2016
$4.56 B(+22.9%)
$1.15 B(-2.0%)
$4.56 B(+3.8%)
Sep 2016
-
$1.18 B(+2.8%)
$4.40 B(+3.5%)
Jun 2016
-
$1.14 B(+5.0%)
$4.25 B(+5.8%)
Mar 2016
-
$1.09 B(+10.3%)
$4.01 B(+8.2%)
Dec 2015
$3.71 B(+41.9%)
$987.25 M(-4.0%)
$3.71 B(+7.0%)
Sep 2015
-
$1.03 B(+13.0%)
$3.47 B(+11.5%)
Jun 2015
-
$909.78 M(+15.8%)
$3.11 B(+10.3%)
Mar 2015
-
$785.66 M(+5.8%)
$2.82 B(+7.8%)
Dec 2014
$2.61 B(+34.1%)
$742.86 M(+10.8%)
$2.61 B(+7.4%)
Sep 2014
-
$670.20 M(+8.2%)
$2.43 B(+4.8%)
Jun 2014
-
$619.32 M(+6.4%)
$2.32 B(+9.5%)
Mar 2014
-
$582.17 M(+3.5%)
$2.12 B(+8.8%)
Dec 2013
$1.95 B(+50.6%)
$562.30 M(+0.7%)
$1.95 B(+10.0%)
Sep 2013
-
$558.45 M(+33.6%)
$1.77 B(+9.3%)
Jun 2013
-
$418.03 M(+1.8%)
$1.62 B(+9.1%)
Mar 2013
-
$410.61 M(+6.8%)
$1.49 B(+14.8%)
Dec 2012
$1.29 B(+193.0%)
$384.43 M(-5.7%)
$1.29 B(+25.7%)
Sep 2012
-
$407.54 M(+44.2%)
$1.03 B(+42.1%)
Jun 2012
-
$282.56 M(+28.7%)
$724.42 M(+31.9%)
Mar 2012
-
$219.49 M(+82.9%)
$549.28 M(+24.4%)
Dec 2011
$441.61 M(-3.4%)
$119.99 M(+17.2%)
$441.61 M(-2.9%)
Sep 2011
-
$102.38 M(-4.7%)
$454.70 M(-0.7%)
Jun 2011
-
$107.42 M(-3.9%)
$457.92 M(-1.7%)
Mar 2011
-
$111.82 M(-16.0%)
$465.99 M(+2.0%)
Dec 2010
$456.98 M
$133.08 M(+26.0%)
$456.98 M(+8.7%)
DateAnnualQuarterlyTTM
Sep 2010
-
$105.61 M(-8.6%)
$420.32 M(-2.6%)
Jun 2010
-
$115.48 M(+12.3%)
$431.69 M(+6.4%)
Mar 2010
-
$102.82 M(+6.6%)
$405.81 M(+7.5%)
Dec 2009
$377.58 M(+59.0%)
$96.41 M(-17.6%)
$377.58 M(+12.3%)
Sep 2009
-
$116.98 M(+30.6%)
$336.38 M(+18.2%)
Jun 2009
-
$89.60 M(+20.1%)
$284.68 M(+11.3%)
Mar 2009
-
$74.59 M(+35.1%)
$255.74 M(+7.7%)
Dec 2008
$237.53 M(+90.0%)
$55.21 M(-15.4%)
$237.53 M(+30.3%)
Sep 2008
-
$65.29 M(+7.6%)
$182.33 M(+55.8%)
Jun 2008
-
$60.65 M(+7.6%)
$117.04 M(+107.6%)
Mar 2008
-
$56.38 M(+468.6%)
$56.38 M(+2.0%)
Dec 2007
$125.02 M(+126.1%)
-
-
Dec 2006
$55.30 M(-2.4%)
$9.92 M(-21.1%)
$55.30 M(-8.8%)
Sep 2006
-
$12.57 M(-23.6%)
$60.66 M(-0.6%)
Jun 2006
-
$16.45 M(+0.5%)
$61.04 M(+3.0%)
Mar 2006
-
$16.37 M(+7.1%)
$59.28 M(+4.7%)
Dec 2005
$56.64 M(-64.3%)
$15.28 M(+18.0%)
$56.64 M(-33.3%)
Sep 2005
-
$12.95 M(-11.9%)
$84.97 M(-14.6%)
Jun 2005
-
$14.69 M(+7.1%)
$99.56 M(-11.7%)
Mar 2005
-
$13.72 M(-68.5%)
$112.76 M(-29.0%)
Dec 2004
$158.80 M(+212.5%)
$43.62 M(+58.4%)
$158.80 M(+17.2%)
Sep 2004
-
$27.53 M(-1.3%)
$135.55 M(+12.4%)
Jun 2004
-
$27.89 M(-53.3%)
$120.57 M(+19.0%)
Mar 2004
-
$59.77 M(+193.5%)
$101.33 M(+98.6%)
Dec 2003
$50.82 M(+227.8%)
$20.36 M(+62.3%)
$51.03 M(+50.7%)
Sep 2003
-
$12.55 M(+45.1%)
$33.85 M(+29.0%)
Jun 2003
-
$8.65 M(-8.7%)
$26.23 M(+23.2%)
Mar 2003
-
$9.47 M(+197.2%)
$21.29 M(+37.3%)
Dec 2002
$15.51 M(+0.3%)
$3.19 M(-35.4%)
$15.51 M(-0.3%)
Sep 2002
-
$4.93 M(+32.9%)
$15.56 M(+4.9%)
Jun 2002
-
$3.71 M(+0.7%)
$14.84 M(-1.2%)
Mar 2002
-
$3.68 M(+13.7%)
$15.02 M(-2.9%)
Dec 2001
$15.46 M(-64.6%)
$3.24 M(-23.0%)
$15.46 M(-31.6%)
Sep 2001
-
$4.21 M(+8.0%)
$22.62 M(-26.8%)
Jun 2001
-
$3.89 M(-5.6%)
$30.91 M(-23.3%)
Mar 2001
-
$4.13 M(-60.3%)
$40.30 M(-7.6%)
Dec 2000
$43.71 M(+41.5%)
$10.40 M(-16.7%)
$43.62 M(-3.1%)
Sep 2000
-
$12.49 M(-6.0%)
$45.02 M(+5.1%)
Jun 2000
-
$13.28 M(+78.4%)
$42.83 M(+25.1%)
Mar 2000
-
$7.45 M(-36.9%)
$34.25 M(+10.8%)
Dec 1999
$30.90 M(-7.2%)
$11.80 M(+14.6%)
$30.90 M(+23.1%)
Sep 1999
-
$10.30 M(+119.1%)
$25.10 M(+3.3%)
Jun 1999
-
$4.70 M(+14.6%)
$24.30 M(-23.8%)
Mar 1999
-
$4.10 M(-31.7%)
$31.90 M(-4.5%)
Dec 1998
$33.30 M(+37.0%)
$6.00 M(-36.8%)
$33.40 M(+5.4%)
Sep 1998
-
$9.50 M(-22.8%)
$31.70 M(+4.6%)
Jun 1998
-
$12.30 M(+119.6%)
$30.30 M(+25.7%)
Mar 1998
-
$5.60 M(+30.2%)
$24.10 M(-0.4%)
Dec 1997
$24.30 M(+5.7%)
$4.30 M(-46.9%)
$24.20 M(+21.6%)
Sep 1997
-
$8.10 M(+32.8%)
$19.90 M(+68.6%)
Jun 1997
-
$6.10 M(+7.0%)
$11.80 M(+107.0%)
Mar 1997
-
$5.70 M(-181.4%)
$5.70 M(-181.4%)
Dec 1996
$23.00 M(-518.2%)
-
-
Sep 1993
-
-$7.00 M(+133.3%)
-$7.00 M(+48.9%)
Dec 1991
-$5.50 M(+323.1%)
-$3.00 M(+500.0%)
-$4.70 M(+176.5%)
Sep 1991
-
-$500.00 K(-58.3%)
-$1.70 M(+41.7%)
Jun 1991
-
-$1.20 M
-$1.20 M
Dec 1990
-$1.30 M
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual gross profit?
  • What is the all time high annual gross profit for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual gross profit year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly gross profit?
  • What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?
  • What is Regeneron Pharmaceuticals TTM gross profit?
  • What is the all time high TTM gross profit for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?

What is Regeneron Pharmaceuticals annual gross profit?

The current annual gross profit of REGN is $12.23 B

What is the all time high annual gross profit for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual gross profit is $13.63 B

What is Regeneron Pharmaceuticals annual gross profit year-on-year change?

Over the past year, REGN annual gross profit has changed by +$930.10 M (+8.23%)

What is Regeneron Pharmaceuticals quarterly gross profit?

The current quarterly gross profit of REGN is $3.22 B

What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly gross profit is $4.44 B

What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?

Over the past year, REGN quarterly gross profit has changed by +$306.50 M (+10.51%)

What is Regeneron Pharmaceuticals TTM gross profit?

The current TTM gross profit of REGN is $12.23 B

What is the all time high TTM gross profit for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM gross profit is $13.97 B

What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?

Over the past year, REGN TTM gross profit has changed by +$930.10 M (+8.23%)